BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22833599)

  • 1. The usefulness of rapid point-of-care creatinine testing for the prevention of contrast-induced nephropathy in the emergency department.
    You JS; Chung YE; Park JW; Lee W; Lee HJ; Chung TN; Chung SP; Park I; Kim S
    Emerg Med J; 2013 Jul; 30(7):555-8. PubMed ID: 22833599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke.
    Sharma J; Nanda A; Jung RS; Mehta S; Pooria J; Hsu DP
    J Neurointerv Surg; 2013 Nov; 5(6):543-5. PubMed ID: 23125428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
    Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
    Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance between serum creatinine and creatinine clearance for identification of ED patients with abdominal pain at risk for contrast-induced nephropathy.
    Band RA; Gaieski DF; Mills AM; Sease KL; Shofer FS; Robey JL; Hollander JE
    Am J Emerg Med; 2007 Mar; 25(3):268-72. PubMed ID: 17349899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the hydration state in emergency patients: correlation between caval index and BUN/creatinine ratio.
    Riccardi A; Chiarbonello B; Minuto P; Guiddo G; Corti L; Lerza R
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1800-3. PubMed ID: 23852907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrast-induced nephropathy: a critical overview.
    Martínez Lomakin F; Tobar C
    Crit Rev Clin Lab Sci; 2014 Dec; 51(6):332-43. PubMed ID: 25033794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care measurement of serum creatinine in the intensive care unit.
    Calzavacca P; Tee A; Licari E; Schneider AG; Bellomo R
    Ren Fail; 2012; 34(1):13-8. PubMed ID: 22011242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography.
    Traub SJ; Kellum JA; Tang A; Cataldo L; Kancharla A; Shapiro NI
    Acad Emerg Med; 2013 Jan; 20(1):40-5. PubMed ID: 23570477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive bedside point of care testing in critical ED patients: a before and after study.
    Singer AJ; Williams J; Taylor M; Le Blanc D; Thode HC
    Am J Emerg Med; 2015 Jun; 33(6):776-80. PubMed ID: 25836947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial.
    Erol T; Tekin A; Katırcıbaşı MT; Sezgin N; Bilgi M; Tekin G; Zümrütdal A; Sezgin AT; Müderrisoğlu H
    Int J Cardiol; 2013 Aug; 167(4):1396-9. PubMed ID: 22572633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can urine dipstick be used as a surrogate for serum creatinine in emergency department patients who undergo contrast studies?
    Firestone D; Wos A; Killeen JP; Chan TC; Guluma K; Davis DP; Vilke GM
    J Emerg Med; 2007 Aug; 33(2):119-22. PubMed ID: 17692759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department.
    Kankaanpää M; Raitakari M; Muukkonen L; Gustafsson S; Heitto M; Palomäki A; Suojanen K; Harjola VP
    Scand J Trauma Resusc Emerg Med; 2016 Oct; 24(1):125. PubMed ID: 27756354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for a point of care testing: an evidence-based appraisal.
    Collinson PO
    Scand J Clin Lab Invest Suppl; 1999; 230():67-73. PubMed ID: 10389204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care creatinine testing in patients receiving contrast-enhanced computed tomography scan.
    Bargnoux AS; Beaufils O; Oguike M; Lopasso A; Dupuy AM; Sebbane M; Badiou S; Fesler P; Cristol JP
    Clin Chim Acta; 2018 Mar; 478():111-113. PubMed ID: 29269201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.
    Wacker-Gußmann A; Bühren K; Schultheiss C; Braun SL; Page S; Saugel B; Schmid S; Mair S; Schoemig A; Schmid RM; Huber W
    AJR Am J Roentgenol; 2014 Feb; 202(2):452-8. PubMed ID: 24450691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-induced nephropathy risk due to emergency contrast-enhanced computed tomography.
    Durukan P; Ozkan S; Ikizceli I; Vardar A; Ipekci A; Duman A
    Eur J Emerg Med; 2012 Feb; 19(1):20-3. PubMed ID: 21552131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
    Torigoe K; Tamura A; Watanabe T; Kadota J
    Int J Cardiol; 2013 Sep; 167(5):2200-3. PubMed ID: 22717305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated blood urea nitrogen/creatinine ratio is associated with poor outcome in patients with ischemic stroke.
    Schrock JW; Glasenapp M; Drogell K
    Clin Neurol Neurosurg; 2012 Sep; 114(7):881-4. PubMed ID: 22333035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
    Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.